| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.22B | -1.3% |
| Cost of Revenue | $1.30B | +0.0% |
| Gross Profit | $924.9M | -3.2% |
| R&D Expense | $57.6M | -1.4% |
| SG&A Expense | $425.0M | -1.2% |
| Operating Income | $96.6M | -51.5% |
| Interest Expense | $73.2M | -4.3% |
| Pre-tax Income | $23.6M | -80.5% |
| Income Tax | -$1.8M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $137.8M | +26.0% |
| Inventory | $484.7M | +1.6% |
| Current Assets | $995.5M | +6.4% |
| Total Assets | $3.76B | +0.7% |
| Current Liabilities | $565.5M | +0.3% |
| Long-term Debt | $1.39B | +8.3% |
| Total Liabilities | $2.20B | +2.6% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $118.4M | -48.7% |
| Investing Cash Flow | -$72.9M | -16.8% |
| Financing Cash Flow | -$30.0M | +83.3% |
| -108.1% |
| Net Income | $25.4M | -74.2% |
| EPS (Basic) | $0.53 | -73.2% |
| EPS (Diluted) | $0.53 | -73.1% |
| Stockholders' Equity |
| $1.55B |
| -2.0% |